Lotus Bio-Technology Development

Lotus Bio-Technology Development Documents

Documents

95

Ticker

LBTD

ISIN

US54570R1077

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Lotus Bio-Technology Development SEC Filings

Type
Report
Date
DD-Formular12/23/2022
15-12G15-12G-Formular6/9/2021
10-Q/A10-Q/A-Formular4/7/2021
10-Q/A10-Q/A-Formular2/23/2021
10-Q/A10-Q/A-Formular1/27/2021
10-K/A10-K/A-Formular1/21/2021
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/20/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/10/2019
NT 10-KNT 10-K-Formular6/29/2018
10-QQuartalsbericht2/13/2018
10-QQuartalsbericht11/13/2017
10-Q/A10-Q/A-Formular9/13/2017
10-QQuartalsbericht8/21/2017
NT 10-QNT 10-Q-Formular8/14/2017
10-KJahresbericht7/14/2017
NT 10-KNT 10-K-Formular6/29/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/19/2017
10-QQuartalsbericht5/8/2017
NT 10-QNT 10-Q-Formular2/14/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/10/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/29/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/28/2016
10-QQuartalsbericht11/21/2016
NT 10-QNT 10-Q-Formular11/14/2016
10-QQuartalsbericht9/27/2016
10-KJahresbericht9/27/2016
NT 10-K/ANT 10-K/A-Formular6/30/2016
NT 10-KNT 10-K-Formular6/29/2016
S-8 POSS-8 POS-Formular4/11/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/8/2016
S-8 POSS-8 POS-Formular4/5/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/1/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/1/2016
10-QQuartalsbericht2/16/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/19/2016
S-8 POSS-8 POS-Formular11/17/2015
10-QQuartalsbericht11/16/2015
S-8 POSS-8 POS-Formular10/9/2015
10-Q/A10-Q/A-Formular9/10/2015
S-8 POSS-8 POS-Formular8/31/2015
S-8S-8-Formular8/25/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/17/2015
10-QQuartalsbericht8/12/2015
10-KJahresbericht7/29/2015
10-Q/A10-Q/A-Formular7/17/2015
NT 10-KNT 10-K-Formular6/30/2015
10-QQuartalsbericht2/23/2015
10-QQuartalsbericht11/18/2014
NT 10-QNT 10-Q-Formular11/14/2014
10-QQuartalsbericht8/19/2014
NT 10-QNT 10-Q-Formular8/14/2014
10-KJahresbericht7/15/2014
NT 10-KNT 10-K-Formular6/30/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/12/2014
10-K/A10-K/A-Formular4/25/2014
10-QQuartalsbericht2/24/2014
NT 10-QNT 10-Q-Formular2/18/2014
10-QQuartalsbericht11/14/2013
10-QQuartalsbericht8/14/2013
10-KJahresbericht7/1/2013
10-Q/A10-Q/A-Formular2/25/2013
10-Q/A10-Q/A-Formular2/25/2013
10-K/A10-K/A-Formular2/25/2013
10-QQuartalsbericht2/19/2013
NT 10-QNT 10-Q-Formular2/15/2013
10-QQuartalsbericht11/13/2012
10-QQuartalsbericht8/2/2012
33-Formular7/2/2012
8-A12G8-A12G-Formular6/25/2012
10-KJahresbericht6/22/2012
424B3424B3-Formular4/3/2012
EFFECTEFFECT-Formular3/29/2012
CORRESPCORRESP-Formular3/26/2012
S-1/AS-1/A-Formular3/20/2012
S-1/AS-1/A-Formular3/13/2012
UPLOADUPLOAD-Formular3/12/2012
S-1/AS-1/A-Formular3/5/2012
UPLOADUPLOAD-Formular3/2/2012
S-1/AS-1/A-Formular2/21/2012
UPLOADUPLOAD-Formular2/14/2012
S-1/AS-1/A-Formular1/31/2012
UPLOADUPLOAD-Formular1/30/2012
S-1/AS-1/A-Formular1/13/2012
UPLOADUPLOAD-Formular1/12/2012
S-1/AS-1/A-Formular12/28/2011
UPLOADUPLOAD-Formular12/23/2011
S-1/AS-1/A-Formular12/16/2011
UPLOADUPLOAD-Formular11/18/2011
S-1/AS-1/A-Formular11/4/2011
UPLOADUPLOAD-Formular10/17/2011
S-1/AS-1/A-Formular10/3/2011
UPLOADUPLOAD-Formular8/19/2011
S-1/AS-1/A-Formular8/9/2011
UPLOADUPLOAD-Formular7/6/2011
S-1S-1-Formular6/10/2011

Lotus Bio-Technology Development Documents 2026

This page contains all official documents and SEC filings for Lotus Bio-Technology Development stock (LBTD, ISIN: US54570R1077). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 95 documents are available. Data is updated regularly to provide investors with a complete overview of Lotus Bio-Technology Development's regulatory filings.